Ruwayda Dham

573 citations

32 papers · 433 indexed · h-index 14

Co-authors: Bishara S. Atiyeh Kusai A. El-Musa Nasir Idkaidek Naji M. Najib Isra Dmour Qamar uz Zaman J. Ioannovich Gilberto De Nucci
Topics: Pharmacogenetics and Drug Metabolism (8 papers)Pharmaceutical studies and practices (8 papers)Wound Healing and Treatments (7 papers)
Cited by: Rehabilitation Dermatology Occupational Therapy
Journals: SHILAP Revista de lepidopterologíaEuropean Journal of Pharmaceutics and Biopharmaceutics Dermatologic Surgery
Partner nations: Lebanon Saudi Arabia United Arab Emirates

In The Last Decade

Ruwayda Dham

31 papers receiving 415 citations

Peers

Countries citing papers authored by Ruwayda Dham

Since Specialization

Citations

This map shows the geographic impact of Ruwayda Dham's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ruwayda Dham with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ruwayda Dham more than expected).

Fields of papers citing papers by Ruwayda Dham

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ruwayda Dham. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ruwayda Dham. The network helps show where Ruwayda Dham may publish in the future.

Co-authorship network of co-authors of Ruwayda Dham

This figure shows the co-authorship network connecting the top 25 collaborators of Ruwayda Dham. A scholar is included among the top collaborators of Ruwayda Dham based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ruwayda Dham. Ruwayda Dham is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Therapeutic Equivalence and mg:mg Switch Ability of a Generic Cyclosporine Microemulsion Formulation (Sigmasporin Microral) in Stable Renal Transplant Patients Maintained on Sandimmun Neoral 2008 ·Transplantation Proceedings ·(unknown),(unknown),(unknown),(unknown),(unknown),Nauman Tarif,(unknown),(unknown),(unknown),(unknown),Ruwayda Dham,Dalia S. Shaker	6
2	Six-Month Clinical Outcome of Cyclosporine Microemulsion Formulation (Sigmasporin Microral) in Stable Renal Transplant Patients Previously Maintained on Sandimmun Neoral 2008 ·Transplantation Proceedings ·(unknown),F A Shaheen,(unknown),(unknown),(unknown),Nauman Tarif,(unknown),(unknown),(unknown),(unknown),Ruwayda Dham,Dalia S. Shaker	7
3	Importance of Helicobacter pylori eradcation for maintenance of remission of drug associated peptic ulcer disease 2006 ·Saudi Journal of Gastroenterology ·(unknown),Ruwayda Dham,(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),Ossama Ashraf Ahmed,(unknown),Mohamed Ismail Nounou,(unknown)	0
4	Comparative pharmacokinetics of two tablet formulations of Losartan: bioequivalence assessment 2005 ·Biopharmaceutics & Drug Disposition ·(unknown),Isam I. Salem,(unknown),Qamar uz Zaman,Ruwayda Dham	20
5	Bioequivalence evaluation of two brands of lisinopril tablets (Lisotec and Zestril) in healthy human volunteers 2005 ·Biopharmaceutics & Drug Disposition ·(unknown),Isam I. Salem,(unknown),Qamar uz Zaman,Ruwayda Dham	10
6	Comparative bioavailability of two brands of atenolol 100 mg tablets (Tensotin and Tenormin) in healthy human volunteers 2004 ·Biopharmaceutics & Drug Disposition ·Naji M. Najib,Nasir Idkaidek,(unknown),Baba Sulemana Mohammed,(unknown),Isra Dmour,(unknown),Ruwayda Dham,(unknown)	6
7	Moist Exposed Therapy: An Effective and Valid Alternative to Occlusive Dressings for Postlaser Resurfacing Wound Care 2004 ·Dermatologic Surgery ·Bishara S. Atiyeh,Ruwayda Dham,Michel Costagliola,(unknown),Lakhdar Belhaouari	13
8	Bioequivalence assessment of Lovrak (Julphar, UAE) compared with Zovirax (Glaxo Wellcome, UK)‐Two brands of Acyclovir‐in healthy human volunteers 2004 ·Biopharmaceutics & Drug Disposition ·Naji M. Najib,Nasir Idkaidek,(unknown),Baba Sulemana Mohammed,Isra Dmour,(unknown),Ruwayda Dham,(unknown)	8
9	The new rHuEPO alpha (epotin) in the management of anemia of end-stage renal disease in patients on mantainence hemodialysis 2004 ·Transplantation Proceedings ·(unknown),(unknown),Jamal Al Wakeel,Mohamed A. Bakr,Ruwayda Dham,Ahmed Farouk Donia,(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),Dalia S. Shaker,(unknown),(unknown)	2
10	Bioequivalence evaluation of two brands of aceclofenac 100mg tablets (Aceclofar and Bristaflam) in healthy human volunteers 2004 ·Biopharmaceutics & Drug Disposition ·Naji M. Najib,Nasir Idkaidek,(unknown),(unknown),Isra Dmour,(unknown),Qamar uz Zaman,Ruwayda Dham	14
11	Pharmacokinetics and bioequivalence evaluation of two simvastatin 40 mg tablets (Simvast & Zocor) in healthy human volunteers 2003 ·Biopharmaceutics & Drug Disposition ·Naji M. Najib,Nasir Idkaidek,(unknown),Isra Dmour,(unknown),Gilberto De Nucci,(unknown),Ruwayda Dham,(unknown)	36
12	Bioequivalence evaluation of two brands of furosemide 40mg tablets (Salurin and Lasix) in healthy human volunteers 2003 ·Biopharmaceutics & Drug Disposition ·Naji M. Najib,Nasir Idkaidek,(unknown),(unknown),Isra Dmour,(unknown),Qamar uz Zaman,Ruwayda Dham	8
13	Scar Quality and Physiologic Barrier Function Restoration After Moist and Moist-Exposed Dressings of Partial-Thickness Wounds 2003 ·Dermatologic Surgery ·Bishara S. Atiyeh,Kusai A. El-Musa,Ruwayda Dham	58
14	Bioequivalence evaluation of two brands of enalapril 20mg tablets (narapril and renitec) in healthy human volunteers 2003 ·Biopharmaceutics & Drug Disposition ·Naji M. Najib,Nasir Idkaidek,(unknown),Isra Dmour,(unknown),Gilberto De Nucci,(unknown),Ruwayda Dham,(unknown)	17
15	Improving Scar Quality: A Prospective Clinical Study 2002 ·Aesthetic Plastic Surgery ·Bishara S. Atiyeh,J. Ioannovich,(unknown),Kusai A. El-Musa,Ruwayda Dham	32
16	Bioequivalence evaluation of two brands of metformin 500 mg tablets (Dialon^® & Glucophage^®) – in healthy human volunteers 2002 ·Biopharmaceutics & Drug Disposition ·Naji M. Najib,Nasir Idkaidek,(unknown),(unknown),Isra Dmour,(unknown),Qamar uz Zaman,Ruwayda Dham	23
17	Bioequivalence evaluation of two brands of gliclazide 80 mg tablets (Glyzide^® & Diamicron^®) — in healthy human volunteers 2002 ·Biopharmaceutics & Drug Disposition ·Naji M. Najib,Nasir Idkaidek,(unknown),(unknown),Isra Dmour,(unknown),Qamar uz Zaman,Ruwayda Dham	16
18	Bioequivalence evaluation of lansoprazole 30-mg capsules (Lanfast® and Lanzor®) in healthy volunteers 2001 ·European Journal of Pharmaceutics and Biopharmaceutics ·(unknown),James D. Carlson,William R. Henderson,Gary R. Erdmann,(unknown),Ruwayda Dham,(unknown)	16
19	Bioequivalence assessment of Azomycin® (Julphar, UAE) as compared to Zithromax® (Pfizer, USA)—two brands of azithromycin—in healthy human volunteers 2001 ·Biopharmaceutics & Drug Disposition ·Naji M. Najib,Nasir Idkaidek,(unknown),Isra Dmour,(unknown),Qamar uz Zaman,Ruwayda Dham	11
20	Bioequivalence evaluation of lomefloxacin 400 mg tablets (Lomax® Versus Maxaquin®) in healthy human volunteers 1999 ·Biopharmaceutics & Drug Disposition ·Khalid A. Al‐Rashood,(unknown),(unknown),(unknown),Mohammed Al‐Yamani,(unknown),Ruwayda Dham	1

About Ruwayda Dham

Ruwayda Dham is a scholar working on Rehabilitation, Occupational Therapy and Pharmacology, having authored 32 papers that have together received 433 indexed citations. Recurring topics across this work include Pharmacogenetics and Drug Metabolism (8 papers), Pharmaceutical studies and practices (8 papers) and Wound Healing and Treatments (7 papers). The work is most often cited by research in Rehabilitation (123 citations), Dermatology (77 citations) and Occupational Therapy (30 citations). Ruwayda Dham has collaborated with scholars based in Lebanon, Saudi Arabia and United Arab Emirates. Frequent co-authors include Bishara S. Atiyeh, Kusai A. El-Musa, Nasir Idkaidek, Naji M. Najib, Isra Dmour, Qamar uz Zaman, J. Ioannovich, Gilberto De Nucci, Ahmed Samir and Mohamed F. Yassin. Their work appears in journals such as SHILAP Revista de lepidopterología, European Journal of Pharmaceutics and Biopharmaceutics and Dermatologic Surgery.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact